DRKS00023072已完成不适用
Characterization of health-relevant compounts of breast milk
Forschungsdepartment Kinderernährung, Universitätsklinik für Kinder- und Jugendmedizin, St. Josef-Hospital, Ruhr-Universität Bochum0 个研究点目标入组 94 人开始时间: 2020年10月20日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 94
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- Female
入选标准
- •Women from the age of 18 years, who have recently given birth;
- •Women who intend to breastfeed fully or partially for at least 3 months;
- •Availability of a freezer (-18°C)
排除标准
- •Mothers of premature babies (< 2500 g, < 37 weeks of pregnancy);
- •Presence of type 1, type 2 or gestational diabetes mellitus;
- •Insufficient knowledge of the German language
研究者
相似试验
尚未招募
不适用
Effects of high amylose wheat flour on the metabolic health of healthy Australian adultsmetabolic healthMetabolic and Endocrine - Normal metabolism and endocrine development and functionDiet and Nutrition - Other diet and nutrition disordersACTRN12616001289404CSIRO20
招募中
不适用
Effects of body electrical stimulation after the stomach reduction surgeryMorbidly obese patients undergoing bariatric surgeryC18.654.726.500.700E02.065.062RBR-99qw5hniversidade Federal de São Carlos
进行中（未招募）
1 期
A Study exploring the Biologic Effects and Biomarkers of Nivolumab in combination with Ipilimumab in Subjects with Non-Small Cell Lung Cancer (NSCLC)EUCTR2018-000462-11-ESBristol-Myers Squibb International Corporation250
进行中（未招募）
1 期
A Study exploring the Biologic Effects and Biomarkers of Nivolumab in combination with Ipilimumab in Subjects with Non-Small Cell Lung Cancer (NSCLC)Treatment-Naive Stage IV or recurrent Non-Small Cell Lung Cancer (NSCLC)MedDRA version: 21.1Level: PTClassification code 10059515Term: Non-small cell lung cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.1Level: LLTClassification code 10080083Term: Advanced lung cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2018-000462-11-BEBristol-Myers Squibb International Corporation250
进行中（未招募）
1 期
A Study exploring the Biologic Effects and Biomarkers of Nivolumab incombination with Ipilimumab in Subjects with Non-Small Cell Lung Cancer(NSCLC)Treatment-Naive Stage IV or recurrent Non-Small Cell Lung Cancer(NSCLC)MedDRA version: 20.0Level: LLTClassification code 10007096Term: Cancer of lungSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.1Level: PTClassification code 10059515Term: Non-small cell lung cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2018-000462-11-ITBRISTOL-MYERS SQUIBB INTERNATIONAL CORPORATIO250